Symmetry Surgical (SSRG) Reports Q1 EPS of $0.03

Symmetry Surgical (NASDAQ: SSRG) reported Q1 EPS of $0.03, versus $0.08 reported last year. Revenue for the quarter came in at $21.2 million, versus $20.8 million reported last year.

Thomas J. Sullivan, President and Chief Executive Officer of Symmetry Surgical, stated, “Our first quarter results include continued momentum in our U.S. business, which was up 5%, partially offset by lower international results, where the strength of the U.S. dollar impacted our business.”

NOTE: The company previously agreed to be acquired acquired with an equity value of approximately $140 million by an affiliate of RoundTable Healthcare Partners

For earnings history and earnings-related data on Symmetry Surgical (SSRG) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c